Our comprehensive brain health assessment combines advanced blood-based biomarker analysis associated with Alzheimer’s disease and digital cognitive testing to provide a broader understanding of biological and cognitive health. By bringing together insights into key Alzheimer’s-associated biomarkers with objective measures of memory, attention, learning and executive function, the assessment supports a more informed evaluation of an individual’s brain health. Combined with expert clinical interpretation, this integrated approach helps guide personalised decision-making and appropriate next steps.
What’s included
Advanced blood biomarker analysis associated with Alzheimer’s disease, including indicators linked to amyloid plaques and tau pathology
Measurement of key biomarkers and protein ratios associated with Alzheimer’s disease
Digital cognitive assessment using CANTAB Insight and/or CANTAB One to evaluate key aspects of cognitive function, including memory, attention, learning and executive function
Objective insights into cognitive performance to help establish a baseline and identify areas that may warrant further investigation
Integration of biological results, cognitive performance and relevant clinical information to support a more comprehensive assessment
Review and interpretation by an experienced clinician
Dedicated health advisory support to guide you through your results and appropriate next steps
Access to appointments and a streamlined clinical pathway in central London